≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback
info icon

Intentional self-harm by jumping from a high place

DOID Endpoint Browser

VWXY20_INTENTI_SELF_H_JUMPI_A_HIGH_PLACE

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — X80
  • Cause of death: ICD-10 — X80

2 out of 7 registries used, show all original rules.

208

4. Check minimum number of events

None

208

5. Include endpoints

None

208

6. Filter based on genotype QC (FinnGen only)

208

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF4
Parent code in ICD-10
X[6-7]|X8[0-4]

Similar endpoints

↥

List of similar endpoints to Intentional self-harm by jumping from a high place based on the number of shared cases.

Venn diagram with an highlighted set fully inside another set Similar with more cases:

Venn diagram with a set fully inside an highlighted set Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

All Female Male
Number of individuals 208 102 106
Unadjusted period prevalence (%) 0.04 0.03 0.05
Median age at first event (years) 31.03 30.06 31.96

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
182
Matched controls
1818
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
X80
ICD-10 Finland
Intentional self-harm by jumping from a high place
+∞
260.1
181
*
W17
ICD-10 Finland
Other fall from one level to another
31.8
64.8
89
53
S32.0
ICD-10 Finland
Fracture of lumbar vertebra
84.2
53.3
58
10
N05AH03
ATC
olanzapine; systemic
20.6
52.1
83
71
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
18.5
49.3
82
77
S32.7
ICD-10 Finland
Multiple fractures of lumbar spine and pelvis
+∞
48.1
44
*
T36
ICD-10 Finland
Poisoning by systemic antibiotics
23.4
45.9
68
45
N05AX08
ATC
risperidone; systemic
18.0
40.9
67
57
F29
ICD-10 Finland
Unspecified nonorganic psychosis
19.4
39.3
62
47
N05AH04
ATC
quetiapine; oral
9.0
37.9
100
216
F32.9
ICD-10 Finland
Depressive episode, unspecified
9.5
35.0
84
151
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
14.1
34.3
62
64
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
19.2
33.9
53
38
N05AH02
ATC
clozapine; systemic
28.0
32.9
45
21
N05AA02
ATC
levomepromazine; systemic
19.3
31.6
49
34
F20.9
ICD-10 Finland
Schizophrenia, unspecified
29.0
30.4
41
18
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
11.3
29.7
60
76
S92.0
ICD-10 Finland
Fracture of calcaneus
47.7
29.3
35
9
N05BA01
ATC
diazepam; systemic, rectal
9.5
28.0
63
96
N05BA06
ATC
lorazepam; systemic, sublingual
21.9
27.3
40
23
NE1AA
NOMESCO Finland
Pelvis X-ray examination
21.9
27.3
40
23
NEJ50
NOMESCO Finland
Operation of fracture of pelvic ring
+∞
26.7
25
*
N07BB01
ATC
disulfiram; oral
13.0
26.7
49
50
AA1AD
NOMESCO Finland
CT of head and brain
7.3
25.9
72
150
N06AB04
ATC
citalopram; systemic
6.8
25.3
75
170
N05AX12
ATC
aripiprazole; systemic
11.9
25.1
48
53
ZXD05
NOMESCO Finland
Urgent procedure
5.4
24.6
105
369
F60.30
ICD-10 Finland
Emotionally unstable personality disorder, impulsive
32.0
24.6
32
12
JN5BD
NOMESCO Finland
Head and body CT examination for trauma
54.7
24.1
28
6
N05BA04
ATC
oxazepam; oral
5.8
24.0
84
233
N05AF03
ATC
chlorprothixene; systemic
21.3
23.8
35
20
N03AE01
ATC
clonazepam; systemic
14.4
23.7
41
36
NAJ32
NOMESCO Finland
Posterior reduction of fractrue of lumbar spine
261.6
23.2
23
*
NA1AD
NOMESCO Finland
Cervical spine CT examination
17.0
21.9
35
25
JN4BD
NOMESCO Finland
Extensive body CT
12.0
21.8
41
43
F10.29
ICD-10 Finland
Addiction caused by alcohol UNS
18.9
21.6
33
21
N05CD07
ATC
temazepam; oral
11.9
21.2
40
42
F20.00
ICD-10 Finland
Paranoid schizophrenia continuous
26.2
21.2
29
13
N06AX11
ATC
mirtazapine; oral
4.7
20.8
95
341
F32.3
ICD-10 Finland
Severe depressive episode with psychotic symptoms
31.4
20.7
27
10
N03AX09
ATC
lamotrigine; oral
11.8
20.7
39
41
X59
ICD-10 Finland
Exposure to unspecified factor
5.3
20.6
76
216
F10.20
ICD-10 Finland
Alcohol dependence currently independent
22.7
20.3
29
15
N06AX16
ATC
venlafaxine; oral
5.8
20.3
66
162
F60.9
ICD-10 Finland
Personality disorder, unspecified
30.1
19.8
26
10
NH1AA
NOMESCO Finland
Ankle X-ray examination without contrast
10.5
19.4
39
46
F33.2
ICD-10 Finland
Recurrent depressive disorder, current episode severe without psychotic symptoms
10.9
19.4
38
43
N06AB06
ATC
sertraline; oral
6.7
19.3
54
108
N04AA02
ATC
biperiden; systemic
27.3
19.3
26
11
S32.1
ICD-10 Finland
Fracture of sacrum
+∞
19.1
18
*
S32.8
ICD-10 Finland
Fracture of other and unspecified parts of lumbar spine and pelvis
+∞
19.1
18
*
F20.30
ICD-10 Finland
Undifferentiated schizophrenia continuous
20.4
19.0
28
16
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
7.9
18.9
46
75
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
6.0
18.3
56
125
N05CF01
ATC
zopiclone; oral
4.6
18.1
79
262
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
8.0
18.0
43
68
F33.9
ICD-10 Finland
Recurrent depressive disorder, unspecified
10.4
18.0
36
42
F10.21
ICD-10 Finland
Alcohol dependence currently abstinent, but staying in restrictive environment
32.6
17.9
23
8
QDB05
NOMESCO Finland
Revision of wound of skin of lower limb
47.2
17.7
21
5
B18.2
ICD-10 Finland
Chronic viral hepatitis C
24.9
17.4
24
11
N03AG01
ATC
valproic acid; systemic, rectal
8.6
17.3
39
56
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
6.8
17.1
46
86
F19.29
ICD-10 Finland
Addiction caused by several drugs in combination and by other psychoactive substances UNS
31.0
16.9
22
8
F41.9
ICD-10 Finland
Anxiety disorder, unspecified
5.3
16.7
57
144
NG4AA
NOMESCO Finland
Lower leg X-ray examination
19.1
16.6
25
15
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
6.2
16.2
47
97
ZXE13
NOMESCO Finland
Procedure duration 90 to 119 minutes
11.3
15.4
29
30
S82.3
ICD-10 Finland
Fracture of lower end of tibia
18.6
15.2
23
14
X44
ICD-10 Finland
Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances
23.5
15.0
21
10
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
5.4
14.9
49
117
F10.09
ICD-10 Finland
Alcohol intoxication UNS
17.3
14.9
23
15
F19.25
ICD-10 Finland
Addiction caused by several drugs in combination and by other psychoactive substances continuously used
87.3
14.8
16
*
S27.0
ICD-10 Finland
Traumatic pneumothorax
87.3
14.8
16
*
NGJ62
NOMESCO Finland
Internal fixation of fracture of knee or lower leg using plate and screws, other or unspecified
39.7
14.7
18
5
F19.1
ICD-10 Finland
Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use
16.3
14.5
23
16
L28
ICPC
Limited function/disability (L)
6.9
14.3
37
65
ZXE20
NOMESCO Finland
More than three and less than five hours
5.3
14.2
47
113
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
7.2
14.1
35
58
S22.4
ICD-10 Finland
Multiple fractures of ribs
58.1
14.1
16
*
F20.09
ICD-10 Finland
Paranoid schizophrenia UNS
37.2
13.8
17
5
S36.1
ICD-10 Finland
Injury of liver or gallbladder
150.8
13.6
14
*
N06AB03
ATC
fluoxetine; oral
5.5
13.4
42
94
Z2446
NOMESCO Finland
Social worker
7.0
13.4
34
58
ZY010
NOMESCO Finland
Hospital outpatient
8.1
13.3
30
43
N03AX16
ATC
pregabalin; oral
4.2
13.2
58
184
F20.39
ICD-10 Finland
Undifferentiated schizophrenia UNS
31.0
13.2
17
6
S27.3
ICD-10 Finland
Other injuries of lung
54.1
13.1
15
*
S32.5
ICD-10 Finland
Fracture of pubis
54.1
13.1
15
*
N05AB03
ATC
perphenazine; systemic, rectal
12.4
13.0
23
21
N05AN01
ATC
lithium; oral
11.3
12.9
24
24
IEY05
NOMESCO Finland
Dedicated profession-specific psychiatric intervention, individual
9.1
12.9
27
34
F33.30
ICD-10 Finland
Recurrent depression, severe episode without somatic syndrome
34.8
12.8
16
5
NF3AA
NOMESCO Finland
Femur X-ray examination
34.8
12.8
16
5
P72
ICPC
Schizophrenia
22.0
12.7
18
9
ICZ03
NOMESCO Finland
Participation in compiling a psychiatric treatment plan
10.2
12.7
25
28
S32.4
ICD-10 Finland
Fracture of acetabulum
139.2
12.6
13
*
R4110
NOMESCO Finland
Physiotherapy
3.7
12.5
64
230
ZXD35
NOMESCO Finland
Usual procedure
10.5
12.4
24
26
N05AD01
ATC
haloperidol; systemic
12.3
12.4
22
20
ZXE30
NOMESCO Finland
More than five and less than seven hours
11.3
12.4
23
23
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
7.3
12.3
30
48
F25.9
ICD-10 Finland
Schizoaffective disorder, unspecified
23.3
12.3
17
8
F33.10
ICD-10 Finland
Recurrent depression, moderate episode without somatic syndrome
6.6
12.2
32
57
F10.25
ICD-10 Finland
Alcohol dependence continuous use
16.1
12.1
19
13
F10.26
ICD-10 Finland
Alcohol dependence periodic alcoholism
16.1
12.1
19
13
N05AF05
ATC
zuclopenthixol; systemic
50.2
12.1
14
*
P15
ICPC
Chronic alcohol abuse
9.2
12.0
25
31
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
4.8
12.0
42
106
ZY000
NOMESCO Finland
Hospital inpatient
12.3
11.9
21
19
WX730
NOMESCO Finland
Conventional respirator
32.5
11.8
15
5
NHJ50
NOMESCO Finland
Open reduction of fracture of foot or toe
32.5
11.8
15
5
F19.21
ICD-10 Finland
Addiction caused by several drugs in combination and by other psychoactive substances currently independent but staying in a controlling environment
32.5
11.8
15
5
Z3231
NOMESCO Finland
Registered nurse
3.4
11.8
71
286
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
6.1
11.8
33
64
F39
ICD-10 Finland
Unspecified mood [affective] disorder
15.0
11.8
19
14
XF400
NOMESCO Finland
ECG with 12 standard connections
5.4
11.6
36
79
ZXE10
NOMESCO Finland
More than one and less than three hours
3.3
11.5
74
315
Z3226
NOMESCO Finland
Physiotherapist
3.9
11.5
52
168
X58
ICD-10 Finland
Exposure to other specified factors
3.9
11.5
52
168
NH1AD
NOMESCO Finland
Ankle and foot CT
18.6
11.4
17
10
TKC20
NOMESCO Finland
Catheterisation of bladder
9.6
11.4
23
27
WX872
NOMESCO Finland
Intensive care
9.8
11.1
22
25
F61.0
ICD-10 Finland
Mixed personality disorders
13.1
11.1
19
16
F19.20
ICD-10 Finland
Addiction relationship caused by several drugs in combination and by other psychoactive substances currently independent
19.3
10.9
16
9
F11.22
ICD-10 Finland
Addiction-induced dependence is currently independent but uses substitute intermittent medication
23.2
10.9
15
7
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
12.3
10.8
19
17
SPAT1309
SPAT
Guidance related to psychoactive substances / risk behaviour
7.7
10.8
25
37
TPH07
NOMESCO Finland
Cathetrisation of artery
6.9
10.8
27
45
WX408
NOMESCO Finland
General anesthesy, balanced
3.3
10.8
64
255
NGJ70
NOMESCO Finland
External fixation of fracture of knee or lower leg, other or unspecified
63.8
10.8
12
*
W19
ICD-10 Finland
Unspecified fall
5.6
10.8
32
67
S22.0
ICD-10 Finland
Fracture of thoracic vertebra
15.5
10.7
17
12
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
5.9
10.6
30
59
IAA01
NOMESCO Finland
Assessment of need for psychiatric treatment
10.5
10.6
20
21
F60.31
ICD-10 Finland
Emotionally unstable personality disorder, borderline condition
11.6
10.6
19
18
S72.3
ICD-10 Finland
Fracture of shaft of femur
34.8
10.5
13
*
Z76.9
ICD-10 Finland
Person encountering health services in unspecified circumstances
6.0
10.4
29
56
Z76.8
ICD-10 Finland
Persons encountering health services in other specified circumstances
10.1
10.3
20
22
IGY02
NOMESCO Finland
Psychiatric monitoring contact
12.3
10.3
18
16
A46
ICD-10 Finland
Erysipelas
4.9
10.1
34
82
ZZA00
NOMESCO Finland
Split skin graft
18.0
10.1
15
9
Z53.2
ICD-10 Finland
Procedure not carried out because of patient's decision for other and unspecified reasons
18.0
10.1
15
9
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
5.4
9.9
30
64
P19
ICPC
Drug abuse
12.4
9.8
17
15
A06AD11
ATC
lactulose; oral
5.0
9.7
32
75
ZXE02
NOMESCO Finland
Procedure duration 10 to 19 minutes
6.4
9.6
25
44
Z2221
NOMESCO Finland
Medical doctor
3.0
9.6
67
296
NCJ62
NOMESCO Finland
Internal fixation of fracture of forearm using plate
13.4
9.6
16
13
188
Kela drug reimbursment
Psychosis requiring demanding treatment
31.9
9.5
12
*
F60.2
ICD-10 Finland
Dissocial personality disorder
105.3
9.5
10
*
S22.2
ICD-10 Finland
Fracture of sternum
105.3
9.5
10
*
T90.5
ICD-10 Finland
Sequelae of intracranial injury
23.2
9.5
13
6
NFJ99
NOMESCO Finland
Other fracture surgery of femur
+∞
9.5
9
*
T07
ICD-10 Finland
Unspecified multiple injuries
+∞
9.5
9
*
P16
ICPC
Acute alcohol abuse
14.7
9.4
15
11
N39.4
ICD-10 Finland
Other specified urinary incontinence
9.1
9.3
19
23
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
6.1
9.3
25
46
R56.8
ICD-10 Finland
Other and unspecified convulsions
6.4
9.3
24
42
XKD06
NOMESCO Finland
Physiologic investigation of micturition
12.4
9.3
16
14
TNX33
NOMESCO Finland
Custom moulded cast, unspecified region
6.3
9.1
24
43
F19.24
ICD-10 Finland
Addiction relationship caused by several drugs in combination and by other psychoactive substances active addiction
38.8
9.1
11
*
IEV99
NOMESCO Finland
Other psychiatric network intervention
38.8
9.1
11
*
N06AB10
ATC
escitalopram; oral
3.0
9.1
64
281
F10.24
ICD-10 Finland
Alcohol depence active use
13.5
9.0
15
12
NC1AA
NOMESCO Finland
Elbow X-ray examination without contrast
9.4
9.0
18
21
S06.2
ICD-10 Finland
Diffuse brain injury
25.5
9.0
12
5
TPH04
NOMESCO Finland
Cathetrisation of vein
3.5
9.0
46
162
TNX50
NOMESCO Finland
Removal of cutom molded cast and internal stretch
7.3
9.0
21
32
F99
ICD-10 Finland
Mental disorder, not otherwise specified
8.9
8.8
18
22
IGY02
SPAT
NA
52.6
8.8
10
*
TQW11
NOMESCO Finland
Vacuum treatment of wound
52.6
8.8
10
*
IGY01
NOMESCO Finland
Accelerated psychiatric treatment contact
9.7
8.8
17
19
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
3.0
8.6
59
252
S92.3
ICD-10 Finland
Fracture of metatarsal bone
8.6
8.6
18
23
ICB01
NOMESCO Finland
Psychiatric treatment plan, standard
8.6
8.6
18
23
F15.2
ICD-10 Finland
Mental and behavioural disorders due to use of other stimulants, including caffeine, dependence syndrome
29.1
8.6
11
*
N05BA02
ATC
chlordiazepoxide; systemic
13.7
8.5
14
11
QBB05
NOMESCO Finland
Revision of wound of skin of trunk
94.2
8.5
9
*
S36.0
ICD-10 Finland
Injury of spleen
94.2
8.5
9
*
F61
ICD-10 Finland
Mixed and other personality disorders
94.2
8.5
9
*
T91.3
ICD-10 Finland
Sequelae of injury of spinal cord
94.2
8.5
9
*
ZXD00
NOMESCO Finland
Emergency procedure
7.1
8.5
20
31
GBB00
NOMESCO Finland
Tracheostomy
+∞
8.4
8
*
N05BA12
ATC
alprazolam; oral
4.5
8.4
30
77
R4120
NOMESCO Finland
Occupational therapy
6.5
8.3
21
36
F60.3
ICD-10 Finland
Emotionally unstable personality disorder
12.5
8.2
14
12
IGV01
NOMESCO Finland
Psychiatric network contact
18.2
8.2
12
7
F13.25
ICD-10 Finland
Addiction caused by sedative and hypnotic continuous use
18.2
8.2
12
7
C07AA05
ATC
propranolol; systemic
3.0
8.2
54
224
ZZH40
NOMESCO Finland
Substitute of bone
35.1
8.2
10
*
P29
ICPC
Psychological sympt/compl other
4.5
8.1
29
74
ZXE40
NOMESCO Finland
More than seven and less than nine hours
13.9
8.0
13
10
ZXY51
NOMESCO Finland
2-person team, doctor-nurse
10.1
7.9
15
16
A28
ICPC
Limited function/disability NOS
5.2
7.9
24
52
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
5.7
7.9
22
43
SPAT1148
SPAT
Treatment of chronic ulcer or burn
4.3
7.8
29
77
2989X
ICD-9 Finland
Other nonorganic psychoses, Unspecified psychosis
47.0
7.8
9
*
F20.0
ICD-10 Finland
Paranoid schizophrenia
47.0
7.8
9
*
NBJ62
NOMESCO Finland
Internal fixation of fracture of shoulder or upper arm using plate and screws, humerus
47.0
7.8
9
*
F25.10
ICD-10 Finland
Schizoaffective syndrome, depressive type with only concomitant bipolar and schizophrenic symptoms
47.0
7.8
9
*
X57
ICD-10 Finland
Unspecified privation
12.6
7.7
13
11
F20.3
ICD-10 Finland
Undifferentiated schizophrenia
19.4
7.7
11
6
EBA15
NOMESCO Finland
Extraction of large number of teeth
10.7
7.7
14
14
ZXE00
NOMESCO Finland
One hour or less
2.5
7.7
82
453
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
5.4
7.6
22
45
F41.2
ICD-10 Finland
Mixed anxiety and depressive disorder
3.5
7.6
36
119
N06AX12
ATC
bupropion; oral
4.6
7.6
26
64
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.6
7.5
69
349
X78
ICD-10 Finland
Intentional self-harm by sharp object
14.2
7.5
12
9
NAJ22
NOMESCO Finland
Posterior reduction of fractrue of thoracic spine
83.3
7.5
8
*
ZXE01
NOMESCO Finland
Procedure duration 0 to 9 minutes
10.0
7.4
14
15
S02.71
ICD-10 Finland
Multiple fractures involving skull and facial bones, open
+∞
7.3
7
*
G95.8
ICD-10 Finland
Other specified diseases of spinal cord
+∞
7.3
7
*
S06.3
ICD-10 Finland
Focal brain injury
16.6
7.3
11
7
SPAT1220
SPAT
Assessment of need for rehabilitation and/or rehabilitation plan
6.1
7.3
19
34
S06.0
ICD-10 Finland
Concussion
3.6
7.3
33
105
ZXE15
NOMESCO Finland
Procedure duration 120 to 149 minutes
8.5
7.3
15
19
AA400
NOMESCO Finland
Electroconvulsive therapy
31.4
7.2
9
*
NFJ60
NOMESCO Finland
Internal fixation of fracture of other parts of femur with intramedullary nail
31.4
7.2
9
*
NH2AA
NOMESCO Finland
Heel X-ray examination
31.4
7.2
9
*
F13.20
ICD-10 Finland
Addiction relationship caused by sedatives and hypnotics currently independent
31.4
7.2
9
*
X84
ICD-10 Finland
Intentional self-harm by unspecified means
21.0
7.2
10
5
IER04
NOMESCO Finland
Rehabilitative psychiatric group intervention, functional
21.0
7.2
10
5
A41.9
ICD-10 Finland
Sepsis, unspecified
12.7
7.2
12
10
N05AA01
ATC
chlorpromazine; systemic, rectal
12.7
7.2
12
10
S52.0
ICD-10 Finland
Fracture of upper end of ulna
10.7
7.2
13
13
F10.00
ICD-10 Finland
Alcohol-related acute intoxication uncomplicated
10.7
7.2
13
13
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.9
7.1
46
188
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
5.0
7.1
22
49
F31.9
ICD-10 Finland
Bipolar affective disorder, unspecified
6.6
7.0
17
28
NHU20
NOMESCO Finland
Removal of internal fixation device from ankle or foot
6.6
7.0
17
28
F12.1
ICD-10 Finland
Mental and behavioural disorders due to use of cannabinoids, harmful use
17.5
6.8
10
6
Z72.8
ICD-10 Finland
Other problems related to lifestyle
17.5
6.8
10
6
L89
ICD-10 Finland
Decubitus ulcer and pressure area
41.6
6.8
8
*
F10.2
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Dependence syndrome
41.6
6.8
8
*
JN4AE
NOMESCO Finland
Focused Assessment with Sonography for Trauma (FAST) of torso
41.6
6.8
8
*
F20
ICD-10 Finland
Schizophrenia
41.6
6.8
8
*
S22.1
ICD-10 Finland
Multiple fractures of thoracic spine
41.6
6.8
8
*
N03AX12
ATC
gabapentin; oral
3.3
6.8
35
123
IAB08
NOMESCO Finland
Consultation concerning a patient who has attempted suicide
23.5
6.7
9
*
F19.00
ICD-10 Finland
Intoxication caused by several drugs in combination or by other psychoactive substances uncomplicated
23.5
6.7
9
*
N31.2
ICD-10 Finland
Flaccid neuropathic bladder, not elsewhere classified
23.5
6.7
9
*
Z2445
NOMESCO Finland
Psychologist
5.5
6.7
19
38
ZXY49
NOMESCO Finland
Other health care provider
12.9
6.7
11
9
S82.0
ICD-10 Finland
Fracture of patella
12.9
6.7
11
9
Z03.2
ICD-10 Finland
Observation for suspected mental and behavioural disorders
7.3
6.7
15
22
S06.5
ICD-10 Finland
Traumatic subdural haemorrhage
10.6
6.6
12
12
ZXD10
NOMESCO Finland
Scheduled procedure
2.4
6.6
69
369
N05BE01
ATC
buspirone; oral
7.9
6.5
14
19
R41.0
ICD-10 Finland
Disorientation, unspecified
15.0
6.5
10
7
F60.0
ICD-10 Finland
Paranoid personality disorder
72.3
6.5
7
*
F20.02
ICD-10 Finland
Paranoid schizophrenia stable periodically
72.3
6.5
7
*
JAH00
NOMESCO Finland
Laparotomy
9.8
6.4
12
13
Z72.2
ICD-10 Finland
Drug use
9.8
6.4
12
13
S52.5
ICD-10 Finland
Fracture of lower end of radius
4.1
6.4
24
65
IFA01
NOMESCO Finland
Psychiatric pharmacotherapy plan, not specified
11.6
6.4
11
10
F10.30
ICD-10 Finland
Withdrawal symptoms caused by alcohol uncomplicated
18.8
6.3
9
5
F19.59
ICD-10 Finland
Psychotic disorder caused by several drugs in combination and by other psychoactive substances UNS
+∞
6.3
6
*
NEU20
NOMESCO Finland
Removal of internal fixation device from pelvis
+∞
6.3
6
*
AAA27
NOMESCO Finland
Insertion of intracerebral pressure monitoring device
+∞
6.3
6
*
ZXE50
NOMESCO Finland
More than nine and less than 12 hours
27.7
6.3
8
*
E950A
ICD-9 Finland
Suicide and self-inflicted poisoning by solid or liquid substances
27.7
6.3
8
*
K04.5
ICD-10 Finland
Chronic apical periodontitis
2.6
6.2
49
224
N06AB05
ATC
paroxetine; oral
4.0
6.2
24
67
N06AX05
ATC
trazodone; oral
7.1
6.2
14
21
ZXM10
NOMESCO Finland
Intraoperative use of conventional X-ray imaging
4.7
6.2
20
47
ZXY60
NOMESCO Finland
2-person team, nurses
13.1
6.2
10
8
A06AC01
ATC
ispaghula (psylla seeds); oral
2.8
6.2
42
178
ZXA00
NOMESCO Finland
Right side
2.6
6.1
48
218
R33
ICD-10 Finland
Retention of urine
5.4
6.1
17
34

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
37
31
14.30
37.82
17.8
14.5
nmol/l
915.9
782.2
0.55
37
31
(3028707) Methadone [Presence] in Urine by Screen method
48
74
8.13
31.33
5.8
3.0
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
62
129
6.42
30.40
5.9
2.3
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
56
111
6.54
28.74
6.2
3.3
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
91
298
4.65
25.87
3.5
1.9
%
1.8
1.4
2.69
81
281
(3016879) Cocaine [Presence] in Urine
61
154
5.19
23.73
6.2
2.1
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
62
166
4.90
22.38
6.2
2.1
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
62
168
4.83
22.02
6.6
2.1
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
61
165
4.82
21.68
6.1
2.1
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
21
17
13.63
21.52
2.0
1.6
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
121
541
3.96
21.41
5.3
2.9
u/l
33.0
31.2
0.28
110
510
(3027944) Amphetamines [Presence] in Urine
60
167
4.64
20.49
6.4
1.9
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
117
532
3.74
19.76
9.9
6.1
mmol/l
1.2
1.2
1.69
110
490
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
123
595
3.61
18.52
9.9
6.9
mmol/l
1.2
1.2
1.85
99
500
(4198724)
18
16
12.22
17.33
4.9
1.8
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
58
182
4.03
16.60
1.9
1.6
nmol/l
1180.9
1204.9
0.07
48
138
(3023368) Bacteria identified in Blood by Culture
82
335
3.39
15.66
5.4
4.2
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
51
157
3.98
14.87
5.0
6.2
mmol/l
1.0
1.0
0.02
44
144
(3024561) Albumin [Mass/volume] in Serum or Plasma
108
535
3.12
14.68
5.5
4.5
g/l
35.3
37.2
2.34
102
507
(3018418) pH of Serum or Plasma
80
346
3.13
13.59
3.3
3.7
ph
7.4
7.4
0.11
21
67
(3003396) Base excess in Arterial blood by calculation
41
117
4.12
13.18
18.0
12.0
mmol/l
1.0
1.2
0.13
35
91
(3012095) Magnesium [Moles/volume] in Serum or Plasma
56
202
3.43
12.76
4.0
3.1
mmol/l
0.8
0.8
0.62
51
191
(3042936) Bacteria identified in Isolate by Culture
53
185
3.50
12.71
3.5
2.5
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
126
724
2.88
12.41
6.7
5.6
umol/l
10.3
11.5
0.75
118
692
(3015377) Calcium [Moles/volume] in Serum or Plasma
87
418
2.86
11.96
2.7
2.8
mmol/l
2.4
2.4
0.24
76
376
(3009508) Creatinine [Moles/volume] in Urine
81
381
2.84
11.51
4.5
3.1
mmol/l
7.4
9.0
1.34
65
329
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
42
134
3.67
11.47
5.7
2.7
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
77
357
2.84
11.20
3.7
2.4
—
—
—
0
0
(40758558) Short blood count panel - Blood
81
388
2.78
11.04
11.7
6.3
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
62
261
2.96
10.72
1.4
1.4
nmol/l
20.0
20.4
0.06
57
232
(42870588) Differential panel, method unspecified - Blood
94
494
2.65
10.58
9.8
5.1
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
129
793
2.65
10.46
11.8
5.5
e9/l
0.0
0.0
0.02
121
716
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
162
1117
3.04
10.46
8.6
6.7
u/l
76.4
73.5
0.56
155
1053
(3012544) pH of Venous blood
33
95
3.94
10.39
4.0
3.3
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
131
813
2.65
10.39
16.0
6.2
e9/l
0.1
0.2
1.65
123
741
(3001604) Monocytes [#/volume] in Blood
128
790
2.61
10.20
11.6
5.5
e9/l
0.6
0.6
0.46
120
715
(3013826) Glucose [Moles/volume] in Serum or Plasma
131
822
2.60
10.01
9.6
4.7
mmol/l
6.6
6.5
0.09
126
746
(3002032) Base excess in Venous blood by calculation
32
93
3.88
9.93
3.8
3.1
mmol/l
2.3
1.9
0.28
27
71
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
90
476
2.57
9.84
3.2
2.9
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
41
146
3.25
9.35
1.6
1.7
—
—
—
0
0
(3026782) Osmolality of Urine
61
272
2.76
9.34
3.2
2.5
mosm/kgh2o
478.9
575.4
2.60
53
236
(3019198) Lymphocytes [#/volume] in Blood
129
821
2.50
9.30
11.9
5.5
e9/l
2.0
1.9
0.38
121
754
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
76
384
2.54
9.01
3.4
2.0
u/l
506.8
365.2
0.26
70
367
(3000850) Epithelial cells [#/volume] in Urine
61
279
2.68
8.84
2.7
2.5
e6/l
40.2
5.0
0.60
52
250
(3013650) Neutrophils [#/volume] in Blood by Automated count
138
919
2.49
8.81
30.9
9.1
e9/l
4.5
4.1
1.28
131
811
(3030467) Casts [#/volume] in Urine by Automated count
73
366
2.53
8.76
3.1
2.6
e6/l
1.3
0.3
0.71
59
278
(3044889) 12 lead EKG panel
144
993
2.46
8.28
4.9
2.9
—
—
—
0
0
(3015736) pH of Urine
100
593
2.32
8.12
4.1
2.8
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
12
17
7.43
8.08
2.3
1.6
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
43
171
2.91
8.06
3.2
2.6
umol/l
10.7
10.1
0.04
35
148
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
53
236
2.67
8.03
1.8
1.5
pmol/l
129787635.6
435.0
0.49
47
210
(3002173) Hemoglobin [Mass/volume] in Arterial blood
30
97
3.45
7.93
22.2
13.7
g/l
117.0
124.8
1.13
30
90
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
84
466
2.35
7.92
1.8
1.7
pmol/l
102.4
93.9
1.16
46
239
(3017143) Hepatitis C virus Ab [Presence] in Serum
62
300
2.52
7.91
2.0
1.5
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
49
212
2.72
7.84
1.8
1.8
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
12
9
14.05
7.48
3.1
2.0
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
42
173
2.79
7.35
1.6
1.4
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
37
143
2.93
7.27
1.7
1.6
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
80
452
2.25
7.08
5.1
2.7
u/l
57.1
51.9
0.75
72
431
(36304419) Bacteria [Presence] in Urine
70
375
2.31
7.02
3.0
2.6
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
13
24
5.71
6.86
4.4
1.8
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
45
200
2.60
6.76
2.6
2.5
mmol/l
2.4
2.4
0.27
34
167
(3032080) INR in Blood by Coagulation assay
80
463
2.18
6.59
5.4
5.4
inr
1.1
1.1
0.42
29
161
(3018095) Leukocytes [#/volume] in Urine
83
490
2.15
6.48
3.9
3.3
e6/l
115.0
60.7
0.39
58
342
(3000991) Gas panel - Venous blood
26
89
3.20
6.26
9.8
7.5
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
73
416
2.16
6.19
3.3
2.7
e6/l
91.2
51.7
0.30
58
327
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
181
1471
2.78
6.07
6.0
4.2
mu/l
1.6
1.8
2.32
171
1377
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
19
54
3.77
6.04
18.2
18.4
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
11
20
5.75
5.87
2.0
2.4
%
15.6
15.9
—
5
9
(21494755) Public health laboratory ask at order entry panel
8
306
0.23
5.86
1.1
1.3
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
158
1223
2.21
5.69
4.8
3.6
pmol/l
14.5
14.5
0.03
149
1137
(3021589) Normoblasts [#/volume] in Blood
104
696
1.99
5.57
15.5
7.8
e9/l
0.0
0.0
0.80
87
572
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
23
80
3.11
5.39
2.1
1.3
—
—
—
0
0
(3004119) Hemoglobin [Mass/volume] in Venous blood
19
59
3.44
5.32
3.9
3.6
g/l
136.7
135.6
0.07
19
59
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
17
49
3.69
5.30
1.4
1.4
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
13
33
4.14
4.79
6.5
3.4
%
53.2
58.2
0.54
13
33
(3030905) Polymorphonuclear cells [#/volume] in Blood
13
33
4.14
4.79
6.5
3.2
e9/l
3.8
4.4
0.40
13
33
(3021879) Hepatitis B virus core Ab [Presence] in Serum
38
185
2.29
4.62
1.9
1.5
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
74
464
1.92
4.61
2.8
2.1
—
—
—
0
0
(3027273) Bicarbonate [Moles/volume] in Venous blood
16
49
3.45
4.57
3.2
3.9
mmol/l
26.0
24.3
1.24
16
49
(3007853) Bacteria identified in Skin by Aerobe culture
36
175
2.28
4.39
2.1
1.6
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
180
1525
2.34
4.36
5.5
3.3
mmol/l
6.3
5.7
1.37
169
1414
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
158
1283
1.96
4.18
6.7
2.8
u/l
43.8
41.0
0.23
153
1232
(3020891) Body temperature
14
42
3.50
4.12
20.9
3.9
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
40
211
2.11
3.98
2.2
2.3
e6/l
2.4
0.7
0.90
20
118
(40761536) Microorganisms panel - Urine sediment
29
134
2.35
3.96
4.9
3.3
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
17
60
3.00
3.89
1.3
1.2
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
39
206
2.10
3.87
2.3
2.3
e6/l
9.6
3.2
0.86
19
113
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
17
61
2.95
3.79
1.6
1.6
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
101
738
1.72
3.59
3.7
3.0
estimate
0.0
0.0
0.00
28
145
(3019060) Gas panel - Arterial blood
18
69
2.76
3.58
27.8
10.8
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
11
31
3.69
3.53
1.2
1.1
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
6
6
10.24
3.52
3.7
2.3
umol/l
21.9
16.7
—
6
6
(3011397) Hemoglobin [Presence] in Urine by Test strip
51
307
1.88
3.49
2.9
3.0
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
67
439
1.78
3.48
2.1
1.7
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
22
95
2.47
3.47
1.3
1.5
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
52
316
1.86
3.45
1.6
1.9
mg/l
2.8
3.0
0.24
41
273
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
11
32
3.57
3.38
1.4
1.4
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
132
1048
1.71
3.37
4.6
3.8
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
42
246
1.89
3.11
3.9
3.3
ng/l
38.8
681.7
0.86
27
161
(3021601) Nitrite [Presence] in Urine by Test strip
99
741
1.64
3.08
4.9
4.2
estimate
0.0
0.0
0.00
27
148
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
13
46
2.95
2.97
3.2
3.4
%
63.2
53.5
0.64
13
46
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
53
339
1.76
2.94
2.8
2.1
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
99
754
1.60
2.79
3.8
3.0
estimate
0.0
0.0
0.00
29
143
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
124
1459
0.63
2.65
3.9
3.8
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
18
81
2.34
2.62
1.4
1.4
—
—
—
0
0
(3007930) Methemoglobin/Hemoglobin.total in Blood
11
38
3.00
2.62
22.9
18.3
%
1.0
0.8
0.93
11
33
(1616796) Gas panel - Central venous blood
9
25
3.71
2.60
3.0
2.2
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
58
394
1.65
2.56
4.5
3.2
estimate
0.0
0.0
0.50
26
144
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
11
39
2.92
2.51
22.9
17.9
%
3.3
1.5
2.13
11
33
(46235355) HIV 1 and 2 tests - Meaningful Use set
78
573
1.58
2.50
2.8
2.0
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
66
476
1.57
2.26
3.8
2.8
ng/l
20.7
46.6
1.02
44
254
(40760892) CBC W Ordered Manual Differential panel - Blood
60
424
1.58
2.24
11.3
4.6
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
10
36
2.87
2.23
1.2
1.1
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
6
14
4.38
2.16
1.3
2.6
—
—
—
0
0
(3018572) Chloride [Moles/volume] in Blood
8
25
3.29
2.12
31.1
24.3
mmol/l
104.8
104.5
—
8
20
(3039000) Anion gap in Blood
8
25
3.29
2.12
31.1
24.3
mmol/l
10.8
11.6
—
8
20
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
158
1388
1.58
2.07
5.0
4.1
mmol/mol
36.8
37.8
0.58
146
1312
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
10
224
0.42
2.01
1.3
1.5
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
17
312
0.50
2.00
1.2
1.5
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
8
27
3.04
1.95
1.1
1.3
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
40
574
0.62
1.92
2.1
1.7
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
6
17
3.60
1.85
1.2
1.5
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
9
186
0.46
1.72
2.0
1.5
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
182
1677
1.68
1.70
21.9
10.9
mg/l
26.6
21.5
1.44
162
1279
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
10
43
2.39
1.63
1.7
1.6
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
7
159
0.42
1.62
1.1
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
7
26
2.75
1.59
1.3
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
7
26
2.75
1.59
1.3
1.3
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
6
20
3.06
1.59
2.7
2.6
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
29
187
1.64
1.56
1.6
1.9
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
54
702
0.69
1.56
2.7
2.2
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
5
15
3.39
1.53
1.2
1.1
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
7
28
2.55
1.46
1.0
1.3
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
5
16
3.17
1.44
1.0
1.4
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
5
16
3.17
1.44
1.0
1.1
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
6
22
2.78
1.44
1.0
1.2
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
14
75
1.93
1.38
1.5
1.3
—
—
—
0
0
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
5
17
2.99
1.36
1.2
1.0
pmol/l
346.0
310.3
—
5
12
(4034850)
10
47
2.18
1.36
9.5
11.4
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
0
37
0.00
1.36
0.0
1.2
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
0
37
0.00
1.36
0.0
1.1
—
95.2
—
0
8
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
34
238
1.51
1.31
2.0
2.0
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
6
24
2.54
1.31
2.8
2.7
—
—
—
0
0
(40761535) Cells panel - Urine sediment
17
100
1.76
1.28
3.2
2.9
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
165
1517
1.42
1.25
17.0
9.4
ml/min/173m2
102.5
94.6
4.84
133
1229
(3006184) Hemoglobin [Mass/volume] in Capillary blood
6
25
2.44
1.25
2.3
2.6
g/l
128.5
125.6
—
6
20
(3012516) Albumin [Mass/volume] in Urine
38
276
1.46
1.23
2.3
3.4
mg/l
16.1
107.5
2.43
20
184
(3020682) Albumin/Creatinine [Ratio] in Urine
40
294
1.45
1.22
3.0
4.2
mg/mmol
3.1
15.1
2.16
21
194
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
36
484
0.69
1.21
1.7
1.6
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
17
102
1.73
1.20
2.8
1.7
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
5
113
0.43
1.16
1.8
1.5
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
8
39
2.09
1.16
1.0
1.4
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
0
35
0.00
1.16
0.0
1.0
—
0.3
—
0
7
(3008401) Mugwort IgE Ab [Units/volume] in Serum
0
35
0.00
1.16
0.0
1.1
—
0.6
—
0
17
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
5
20
2.54
1.16
1.0
1.2
—
—
—
0
0
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
5
20
2.54
1.16
1.2
1.4
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
73
600
1.33
1.15
4.3
2.9
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
8
40
2.04
1.13
1.0
1.5
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
19
286
0.63
1.11
1.5
3.0
%
22.0
22.8
—
7
92
(3045424) Erythrocytes [Presence] in Urine
5
21
2.41
1.09
1.4
1.0
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
7
32
2.23
1.09
7.0
3.8
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
6
124
0.47
1.09
1.3
1.4
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
20
130
1.60
1.07
12.8
17.0
—
1.2
—
0
20
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
46
356
1.38
1.06
1.7
1.8
mg/l
1.2
0.8
0.80
29
273
(3052851) Hemolysis interference index of Serum or Plasma
7
34
2.09
1.04
5.0
2.6
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
168
1567
1.37
1.01
3.7
3.1
mmol/l
1.5
1.3
1.85
153
1470
(3022313) Gas panel - Capillary blood
10
54
1.89
0.98
3.4
2.9
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
0
30
0.00
0.98
0.0
1.0
—
1.3
—
0
10
(4094501)
0
31
0.00
0.97
0.0
1.1
—
—
—
0
0
(3000492) Spirometry study
11
183
0.58
0.96
1.3
1.3
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
9
52
1.76
0.93
1.0
1.1
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
84
722
1.27
0.92
5.0
4.1
—
—
—
0
0
(3008898) HLA-B27 [Presence]
5
103
0.47
0.92
1.0
1.0
—
—
—
0
0
(3013512) EKG study
42
330
1.34
0.89
4.0
2.9
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
6
33
1.84
0.79
2.0
2.3
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
0
26
0.00
0.79
0.0
1.0
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
0
26
0.00
0.79
0.0
1.0
—
1.1
—
0
8
(3002256) Pathology report gross observation
11
172
0.62
0.77
1.1
1.2
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
9
53
1.73
0.76
1.0
1.1
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
9
53
1.73
0.76
1.0
1.1
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
7
38
1.87
0.74
1.9
1.7
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
9
58
1.58
0.71
1.6
1.3
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
5
91
0.54
0.69
2.2
1.5
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
25
189
1.37
0.68
2.2
2.0
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
52
438
1.25
0.66
2.5
2.3
—
—
—
0
0
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
5
29
1.74
0.64
1.0
1.0
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
30
238
1.30
0.61
1.2
1.3
titre
171.4
378.4
—
7
50
(3000475) Leukocytes [#/volume] in Synovial fluid
0
20
0.00
0.60
0.0
1.3
—
14039.8
—
0
12
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
0
20
0.00
0.60
0.0
1.2
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
0
21
0.00
0.60
0.0
1.1
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
17
123
1.42
0.60
9.5
4.6
%
0.3
0.8
—
6
36
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
0
22
0.00
0.59
0.0
5.0
—
5348.0
—
0
5
(3013707) Erythrocyte sedimentation rate by Westergren method
124
1151
1.19
0.57
3.4
3.4
mm/h
10.4
7.9
1.28
118
1070
(4010399)
5
88
0.56
0.57
1.2
1.3
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
30
367
0.79
0.55
2.3
3.3
ug/l
1.1
1.4
0.72
24
330
(3001122) Ferritin [Mass/volume] in Serum or Plasma
83
747
1.18
0.54
2.6
2.6
ug/l
111.4
90.5
0.71
78
702
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
21
269
0.76
0.54
1.1
1.2
u/ml
1.0
9.4
—
6
110
(3044290) Cell count panel - Cerebral spinal fluid
6
40
1.51
0.52
1.0
1.4
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
46
532
0.83
0.51
1.7
1.6
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
18
137
1.34
0.49
16.3
5.8
—
—
—
0
0
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
7
48
1.47
0.47
1.0
1.3
e6/l
285.3
183.7
—
7
43
(3041096) Erythrocytes [Presence] in Urine by Automated
53
464
1.19
0.47
4.1
2.6
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
16
208
0.75
0.46
1.6
2.1
ug/l
0.6
0.6
—
9
94
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
172
1658
1.22
0.46
4.4
3.5
mmol/l
2.8
2.9
0.17
158
1545
(3004716) Salmonella sp identified in Stool by Organism specific culture
16
121
1.35
0.46
1.1
1.3
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
8
58
1.39
0.42
1.1
1.1
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
5
33
1.53
0.41
2.4
5.0
mg/l
38.4
21.9
—
5
21
(4027681)
0
15
0.00
0.41
0.0
1.3
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
0
15
0.00
0.41
0.0
1.0
—
—
—
0
0
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
0
15
0.00
0.41
0.0
2.9
—
3.0
—
0
15
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
0
16
0.00
0.41
0.0
1.0
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
170
1642
1.19
0.41
4.1
3.4
mmol/l
4.5
4.7
1.17
158
1541
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
45
394
1.18
0.40
2.2
2.1
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
11
148
0.73
0.40
3.8
3.5
%
32.2
30.9
—
5
99
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
0
18
0.00
0.40
0.0
1.1
—
31.5
—
0
13
(3023420) DNA double strand Ab [Units/volume] in Serum
0
18
0.00
0.40
0.0
1.3
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
13
98
1.35
0.38
2.2
2.6
ml/min/173m2
75.5
73.6
—
6
41
(3025941) Bacteria identified in Stool by Culture
8
114
0.69
0.38
1.4
1.2
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
5
37
1.36
0.37
1.0
1.2
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
19
154
1.26
0.35
1.1
1.1
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
185
1806
1.22
0.35
27.2
9.9
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
6
46
1.31
0.33
3.2
2.0
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
34
388
0.85
0.33
1.3
1.3
g/l
2.0
2.2
0.28
15
259
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
26
303
0.84
0.32
1.3
1.5
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
7
56
1.26
0.29
1.1
3.1
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
8
109
0.72
0.29
1.3
1.9
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
14
113
1.26
0.27
11.2
4.8
%
0.0
0.0
—
5
29
(3022145) Colonoscopy Study observation
12
147
0.81
0.24
1.8
1.3
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
7
91
0.76
0.23
1.3
1.7
mg/l
14.1
3.3
—
7
57
(3021440) Promyelocytes/100 leukocytes in Blood
14
116
1.22
0.22
11.2
4.7
%
0.0
0.2
—
5
32
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
5
41
1.22
0.22
1.0
1.3
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
2.0
—
0.9
—
0
11
(3038026) Centromere Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
0
11
0.00
0.21
0.0
4.5
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
0
11
0.00
0.21
0.0
3.8
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.8
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
0
10
0.00
0.21
0.0
2.3
—
—
—
0
0
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.1
—
0.0
—
0
6
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
167
1634
1.11
0.21
4.0
3.3
mmol/l
1.3
1.4
3.12
153
1529
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
2.8
—
830.2
—
0
13
(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
2.0
—
4.1
—
0
13
(40765089) Chromosome analysis panel - Blood by G-banded
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
0
14
0.00
0.20
0.0
1.4
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
0
14
0.00
0.20
0.0
1.6
—
—
—
0
0
(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3034770) Mitochondria Ab [Titer] in Serum
6
50
1.21
0.20
1.0
1.2
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
10
122
0.81
0.19
2.3
2.2
—
15.9
—
0
7
(3045414) Leukocytes [Presence] in Urine
6
52
1.16
0.19
1.3
1.4
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
31
339
0.90
0.17
1.8
1.7
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
5
67
0.74
0.17
1.4
1.4
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
26
287
0.89
0.17
1.2
1.2
iu/ml
8.1
17.3
—
6
87
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
40
430
0.91
0.16
1.3
1.3
u/ml
0.7
1.2
0.74
12
106
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
6
77
0.77
0.16
2.0
1.7
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
32
341
0.93
0.11
1.7
2.4
umol/l
330.1
3809.2
1.08
23
306
(40768797) Stomach Pathology biopsy report
16
176
0.90
0.10
1.1
1.3
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
6
55
1.09
0.09
1.2
1.0
—
5.4
—
0
9
(3000330) Specific gravity of Urine by Test strip
6
56
1.07
0.08
7.2
3.1
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
6
57
1.05
0.08
1.2
1.1
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
13
118
1.11
0.07
1.0
1.0
—
—
—
0
0
(4035726)
8
91
0.87
0.07
1.3
1.3
—
—
—
0
0
(3019225) pH of Specimen
12
109
1.11
0.06
2.1
4.1
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
16
151
1.06
0.03
1.2
1.3
iu/ml
40.0
136.1
—
6
58
(3009542) Hematocrit [Volume Fraction] of Blood
168
1672
1.02
0.01
31.8
11.0
%
39.7
41.3
2.09
113
1404
(1175426) CD3 cells/100 lymphocytes in Blood
0
8
0.00
0.00
0.0
2.4
—
74.4
—
0
8
(3035947) Staphylolysin Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
0
8
0.00
0.00
0.0
1.0
—
20.2
—
0
8
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.8
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
8
0.00
0.00
0.0
1.9
—
—
—
0
0
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
0
8
0.00
0.00
0.0
1.0
—
149.8
—
0
8
(3037556) Urate [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
0
8
0.00
0.00
0.0
3.6
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.0
—
1564.4
—
0
8
(40768800) Prostate Pathology biopsy report
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(21494434) Karyotype in Bone marrow
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
3.5
—
40.3
—
0
6
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3032868) Hemoglobin electrophoresis panel in Blood
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(4146454)
0
5
0.00
0.00
0.0
2.8
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042299) inFLIXimab [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
4.7
—
7.8
—
0
7
(3013247) Albumin in CSF/Albumin in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
4.9
—
0
5
(42529582) MDA5 Ab [Presence] in Serum by Line blot
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
0
6
0.00
0.00
0.0
2.5
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
9
89
1.01
0.00
1.2
1.2
—
—
—
0
0
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
0
6
0.00
0.00
0.0
2.2
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
0
6
0.00
0.00
0.0
5.7
—
—
—
0
0
(3029396) Erythrocyte agglutination [Presence] in Blood
0
6
0.00
0.00
0.0
3.3
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3024263) Appearance of Synovial fluid
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum
0
5
0.00
0.00
0.0
1.2
—
9.4
—
0
5
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(44806071)
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
0
5
0.00
0.00
0.0
1.2
—
47.2
—
0
5
(3006245) CD3-CD19+ cells/100 cells in Blood
0
5
0.00
0.00
0.0
2.8
—
16.2
—
0
5
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3015076) Soybean IgE Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
10
100
1.00
0.00
1.5
1.4
g/l
1.8
1.2
—
10
90
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3034426) Prothrombin time (PT)
0
7
0.00
0.00
0.0
2.0
—
—
—
0
0
(3004451) EKG impression Narrative
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
5
52
0.96
0.00
2.6
2.1
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3017704) Immunofixation for Urine
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(4133840)
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(37021550) Renin [Units/volume] in Plasma --upright
0
6
0.00
0.00
0.0
1.5
—
211.6
—
0
6

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: VWXY20_INTENTI_SELF_H_JUMPI_A_HIGH_PLACE – Intentional self-harm by jumping from a high place

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).